The document provides information about the drug Spironolactone including its classification, mechanism of action, indications, contraindications, adverse effects, and nursing responsibilities. It details the patient's information, diagnosis, dose, and indications for use of treating pregnancy-induced hypertension.
The document provides information about the drug Spironolactone including its classification, mechanism of action, indications, contraindications, adverse effects, and nursing responsibilities. It details the patient's information, diagnosis, dose, and indications for use of treating pregnancy-induced hypertension.
The document provides information about the drug Spironolactone including its classification, mechanism of action, indications, contraindications, adverse effects, and nursing responsibilities. It details the patient's information, diagnosis, dose, and indications for use of treating pregnancy-induced hypertension.
The document provides information about the drug Spironolactone including its classification, mechanism of action, indications, contraindications, adverse effects, and nursing responsibilities. It details the patient's information, diagnosis, dose, and indications for use of treating pregnancy-induced hypertension.
General: > diagnosis and maintenance of primary hyperaldosteronis m > adjunctive therapy in edema > treatment or prevention of hypokalemia > essential hypertension > treatment of hirsutism, palliation of symptoms of PMS, treatment of familial male precocious puberty; short-term treatment of acne vulgaris Patients actual indications: Treatment of pregnancy-induced hypertension
Source: 2011 Lippincotts NDG
CONTRAINDICATI ON
Contraindicated with allergy to spirinolactone, hyperkalemia, renal disease, anuria, amiloride or triamterene use Precautions: Use cautiously with pregnancy, lactation
Interactions: > drug-drug: increased hyperkalemia with potassium supplements, ACE inhibitors, diets rich in potassium, decreased diuretic effect with salicylates > drug-food: increased absorption when taken with food > drug-lab test: interference with radioimmunoassay for digoxin; false increase in serum digoxin levels > drug-alternative therapy: decreased effectiveness if combined with licorice therapy
Source: 2011 Lippincotts NDG
Hematologic: hyperkalemia, hyponatremia Other: carcinogenic in animals, deepening of the voice, hirsutism, gynecomastia
Source: 2011 Lippincotts NDG
NURSING RESPONSIBILITIE S
Before: > Check doctors order. > Review medication record. > Determine potassium levels > Determine renal, hepatic impairment. > Determine hypersensitivity. During: > Introduce self to client. > Confirm clients identity. > Read drug label. > Inform drugs therapeutic effect. > Inform of side effects > Administer in the morning to prevent nocturia After: > Evaluate therapeutic response. > Watch for adverse effects. > Warn patient to avoid excessive ingestion of potassium-rich foods. > Caution patient not to perform hazardous activities if adverse CNS reactions occur. > Report to prescriber the adverse reactions. > document and record.
